Description

Imidazo[1,5-A]Pyrazine, 5,6,7,8-Tetrahydro-3-(1-Methylethyl)- (9Ci) is a high-purity, advanced pharmaceutical intermediate with the CAS number 752200-12-7. This heterocyclic compound is valued for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring complex molecular architectures. It is essential for research and development chemists and process scale-up teams in the pharmaceutical and biotechnology sectors seeking to develop new drug candidates with high efficacy.

Application

• Key synthetic intermediate in the research and development of new pharmaceutical compounds.
• Building block for the synthesis of complex heterocyclic molecules in medicinal chemistry.
• Precursor in the development of potential kinase inhibitors and other targeted therapies.
• Used in process chemistry for the scale-up and optimization of API manufacturing routes.
• Valuable reagent in academic and industrial research for exploring new chemical spaces.
• Component in the synthesis of specialized fine chemicals and agrochemical intermediates.

Basic Information

Item	Details
Product Name	Imidazo[1,5-A]Pyrazine, 5,6,7,8-Tetrahydro-3-(1-Methylethyl)- (9Ci)
CAS No.	752200-12-7
Molecular Formula	C9H14N4
Molecular Weight	178.24 g/mol
Synonyms	3-Isopropyl-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine; 5,6,7,8-Tetrahydro-3-(1-methylethyl)imidazo[1,5-a]pyrazine; 3-Isopropyl-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine; Imidazo[1,5-a]pyrazine, 5,6,7,8-tetrahydro-3-(1-methylethyl)-; 752200-12-7; 3-(Propan-2-yl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine
EINECS	Contact for details

Quality Control

Our production of Imidazo[1,5-A]Pyrazine, 5,6,7,8-Tetrahydro-3-(1-Methylethyl)- (9Ci) adheres to stringent quality management protocols to ensure batch-to-batch consistency and reliability for critical R&D and scale-up processes. Each lot is supported by a comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles. We are committed to meeting the exacting standards required for pharmaceutical intermediate applications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (typically 15-25°C). Keep away from incompatible materials. For long-term storage, consider an inert atmosphere to maintain optimal stability.

Specification

Item	Specification
Appearance	White to off-white powder or crystalline solid
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.